Detailed answers about HYBRID THERAPEUTIC HOMES LIMITED, including incorporation, status, business activity, and accounts information.
When was HYBRID THERAPEUTIC HOMES LIMITED founded?
HYBRID THERAPEUTIC HOMES LIMITED was officially incorporated on 29 April 2026 and is registered under company number 17188310. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is HYBRID THERAPEUTIC HOMES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of HYBRID THERAPEUTIC HOMES LIMITED?
HYBRID THERAPEUTIC HOMES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does HYBRID THERAPEUTIC HOMES LIMITED do?
HYBRID THERAPEUTIC HOMES LIMITED operates in the following sectors: 86900 - Other human health activities, 87100 - Residential nursing care facilities, 87200 - Residential care activities for learning difficulties, mental health and substance abuse, 88910 - Child day-care activities. These SIC codes provide insight into the company's business activities and industry focus.
What is HYBRID THERAPEUTIC HOMES LIMITED's registered address?
The registered office address of HYBRID THERAPEUTIC HOMES LIMITED is 30 Brampton Road, Bexleyheath, England, DA7 4HD. This is the official address filed with Companies House for legal and statutory correspondence.
Is HYBRID THERAPEUTIC HOMES LIMITED financially stable?
Financial accounts for HYBRID THERAPEUTIC HOMES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.